Market Closed -
Bombay S.E.
06:00:50 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
181
INR
|
-0.17%
|
|
+5.48%
|
-20.51%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,667
|
1,345
|
497.4
|
2,101
|
4,600
|
3,268
|
Enterprise Value (EV)
1 |
1,427
|
948.1
|
-90.62
|
1,780
|
4,210
|
2,361
|
P/E ratio
|
12.4
x
|
7.67
x
|
2.94
x
|
6.13
x
|
12.7
x
|
6.45
x
|
Yield
|
0.29%
|
0.36%
|
1.29%
|
1.53%
|
0.7%
|
0.98%
|
Capitalization / Revenue
|
1.65
x
|
1.05
x
|
0.43
x
|
1.46
x
|
2.62
x
|
1.45
x
|
EV / Revenue
|
1.41
x
|
0.74
x
|
-0.08
x
|
1.23
x
|
2.4
x
|
1.05
x
|
EV / EBITDA
|
7.11
x
|
4.32
x
|
-0.44
x
|
3.93
x
|
8.59
x
|
3.65
x
|
EV / FCF
|
151
x
|
8.86
x
|
-0.38
x
|
20.9
x
|
-74
x
|
5.18
x
|
FCF Yield
|
0.66%
|
11.3%
|
-260%
|
4.77%
|
-1.35%
|
19.3%
|
Price to Book
|
1.59
x
|
1.11
x
|
0.36
x
|
1.22
x
|
2.22
x
|
1.28
x
|
Nbr of stocks (in thousands)
|
32,090
|
32,090
|
32,090
|
32,090
|
32,090
|
32,090
|
Reference price
2 |
51.94
|
41.90
|
15.50
|
65.47
|
143.4
|
101.8
|
Announcement Date
|
8/2/18
|
8/21/19
|
9/3/20
|
8/4/21
|
8/2/22
|
7/25/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,009
|
1,283
|
1,153
|
1,442
|
1,757
|
2,251
|
EBITDA
1 |
200.8
|
219.4
|
204
|
453.3
|
490.1
|
647.1
|
EBIT
1 |
187.4
|
206.3
|
191.1
|
442.5
|
479.7
|
631.5
|
Operating Margin
|
18.58%
|
16.08%
|
16.58%
|
30.7%
|
27.3%
|
28.06%
|
Earnings before Tax (EBT)
1 |
203.9
|
241.9
|
223.4
|
465.4
|
499.9
|
689.5
|
Net income
1 |
134
|
175.4
|
169.5
|
342.6
|
363.7
|
506.9
|
Net margin
|
13.29%
|
13.66%
|
14.7%
|
23.77%
|
20.7%
|
22.52%
|
EPS
2 |
4.177
|
5.464
|
5.281
|
10.68
|
11.33
|
15.80
|
Free Cash Flow
1 |
9.439
|
107
|
235.6
|
84.95
|
-56.88
|
456
|
FCF margin
|
0.94%
|
8.33%
|
20.44%
|
5.89%
|
-3.24%
|
20.26%
|
FCF Conversion (EBITDA)
|
4.7%
|
48.76%
|
115.49%
|
18.74%
|
-
|
70.47%
|
FCF Conversion (Net income)
|
7.04%
|
61.01%
|
139.01%
|
24.8%
|
-
|
89.95%
|
Dividend per Share
2 |
0.1500
|
0.1500
|
0.2000
|
1.000
|
1.000
|
1.000
|
Announcement Date
|
8/2/18
|
8/21/19
|
9/3/20
|
8/4/21
|
8/2/22
|
7/25/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
239
|
396
|
588
|
321
|
390
|
907
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
9.44
|
107
|
236
|
85
|
-56.9
|
456
|
ROE (net income / shareholders' equity)
|
13.5%
|
15.5%
|
13%
|
22%
|
19.1%
|
21.9%
|
ROA (Net income/ Total Assets)
|
10.5%
|
10.4%
|
8.5%
|
16.3%
|
14.6%
|
15.9%
|
Assets
1 |
1,272
|
1,693
|
1,994
|
2,098
|
2,496
|
3,191
|
Book Value Per Share
2 |
32.60
|
37.80
|
43.10
|
53.90
|
64.60
|
79.50
|
Cash Flow per Share
2 |
1.430
|
0.7800
|
12.80
|
0.6300
|
11.20
|
26.60
|
Capex
1 |
1.85
|
4.36
|
3.07
|
2.81
|
0.35
|
49.7
|
Capex / Sales
|
0.18%
|
0.34%
|
0.27%
|
0.2%
|
0.02%
|
2.21%
|
Announcement Date
|
8/2/18
|
8/21/19
|
9/3/20
|
8/4/21
|
8/2/22
|
7/25/23
|
|
1st Jan change
|
Capi.
|
---|
| -20.51% | 69.63M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|